The University of Chicago Header Logo

Girish Venkataraman

Concepts (375)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tumor Suppressor Protein p53
7
2026
470
3.240
Why?
Lymphoma, B-Cell
6
2023
110
2.840
Why?
Lymphoma, Large B-Cell, Diffuse
14
2026
197
2.830
Why?
Hodgkin Disease
12
2024
144
2.800
Why?
Lymphoma, T-Cell, Peripheral
5
2023
34
1.800
Why?
Mutation
12
2026
4443
1.570
Why?
Myelodysplastic Syndromes
2
2026
386
1.410
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
4
2024
150
1.120
Why?
Biomarkers, Tumor
10
2026
1786
1.080
Why?
Lymphoproliferative Disorders
4
2023
105
0.990
Why?
Hematologic Neoplasms
3
2026
384
0.970
Why?
Bone Marrow
4
2022
419
0.950
Why?
Chromosome Aberrations
2
2026
353
0.900
Why?
Chromosomes, Human, Pair 5
1
2026
113
0.900
Why?
Leukemia, Myelomonocytic, Chronic
2
2017
25
0.890
Why?
Lymphoma
2
2026
255
0.870
Why?
Mediastinal Neoplasms
2
2022
41
0.870
Why?
Prognosis
14
2026
4139
0.830
Why?
Proto-Oncogene Proteins c-bcl-2
4
2026
213
0.800
Why?
5-Methylcytosine
2
2022
134
0.780
Why?
Humans
81
2026
98799
0.760
Why?
Aged, 80 and over
17
2026
7461
0.740
Why?
Leukemia, Erythroblastic, Acute
1
2022
28
0.720
Why?
Glucose Transporter Type 1
1
2022
46
0.720
Why?
Middle Aged
38
2026
29642
0.700
Why?
Epstein-Barr Virus Infections
5
2019
67
0.700
Why?
Lymphoma, T-Cell
1
2022
60
0.690
Why?
Aged
33
2026
21986
0.670
Why?
Lymphoma, Mantle-Cell
4
2021
45
0.670
Why?
Hypereosinophilic Syndrome
1
2020
6
0.650
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2017
177
0.630
Why?
Adult
33
2026
29698
0.620
Why?
STAT6 Transcription Factor
1
2019
32
0.610
Why?
Leukemia
1
2022
310
0.610
Why?
Bone Marrow Cells
3
2019
269
0.580
Why?
Male
44
2026
47475
0.570
Why?
Leukemia, Myeloid, Acute
1
2025
850
0.570
Why?
Female
41
2026
51997
0.560
Why?
Reed-Sternberg Cells
3
2024
4
0.530
Why?
Lymphoma, Non-Hodgkin
1
2019
262
0.520
Why?
T-Lymphocytes
3
2020
1335
0.490
Why?
Fusion Proteins, bcr-abl
1
2017
111
0.490
Why?
Erythrocyte Aggregation
1
2016
4
0.470
Why?
Infectious Mononucleosis
1
2016
6
0.470
Why?
Diagnosis, Differential
9
2019
1571
0.470
Why?
Adenocarcinoma
3
2008
1215
0.470
Why?
Histiocytosis, Sinus
2
2019
18
0.460
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2025
445
0.460
Why?
Lymphocytes
3
2023
461
0.460
Why?
Pathology, Clinical
2
2025
39
0.450
Why?
Receptors, Antigen, T-Cell
2
2019
454
0.430
Why?
Piperidines
4
2021
177
0.420
Why?
Immunohistochemistry
10
2026
1818
0.410
Why?
Immunoglobulin G
2
2019
481
0.410
Why?
Granulocyte Precursor Cells
1
2013
7
0.400
Why?
CD11c Antigen
1
2013
20
0.400
Why?
Disseminated Intravascular Coagulation
1
2013
29
0.400
Why?
Antigens, CD
2
2013
482
0.390
Why?
Cytoplasmic Granules
1
2013
97
0.390
Why?
Herpesvirus 8, Human
1
2013
11
0.390
Why?
Castleman Disease
1
2013
11
0.390
Why?
Sarcoma, Kaposi
1
2013
17
0.390
Why?
Bone Marrow Neoplasms
1
2013
19
0.380
Why?
Prostatic Neoplasms
4
2008
1846
0.380
Why?
HIV Seropositivity
1
2013
49
0.380
Why?
Neoplasm Staging
7
2024
2087
0.370
Why?
Down-Regulation
2
2022
529
0.370
Why?
B-Lymphocytes
5
2023
737
0.360
Why?
Monocytes
1
2013
219
0.360
Why?
Interleukin-3 Receptor alpha Subunit
1
2011
4
0.350
Why?
Integrin alpha Chains
1
2011
21
0.350
Why?
Leukemia, Hairy Cell
1
2011
73
0.340
Why?
Breast Neoplasms
1
2026
3303
0.340
Why?
Lewis X Antigen
1
2011
9
0.340
Why?
Fucosyltransferases
1
2011
9
0.340
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2011
15
0.330
Why?
Programmed Cell Death 1 Receptor
2
2023
201
0.330
Why?
Hematopoietic Stem Cell Transplantation
3
2026
979
0.330
Why?
Immunophenotyping
5
2025
228
0.330
Why?
Sclerosis
1
2010
30
0.320
Why?
Lymphoma, B-Cell, Marginal Zone
1
2010
23
0.320
Why?
Dura Mater
1
2010
46
0.320
Why?
Autoimmune Lymphoproliferative Syndrome
1
2010
2
0.310
Why?
Histiocytic Sarcoma
1
2010
7
0.310
Why?
Image Cytometry
2
2007
10
0.310
Why?
Meningeal Neoplasms
1
2010
79
0.300
Why?
Flow Cytometry
5
2024
722
0.300
Why?
Clone Cells
2
2025
223
0.300
Why?
Adolescent
13
2025
10168
0.290
Why?
Pyrimidines
3
2018
416
0.290
Why?
Neoplasms
2
2020
3382
0.280
Why?
DNA, Neoplasm
4
2013
267
0.280
Why?
T-Lymphocytes, Helper-Inducer
2
2023
150
0.270
Why?
Neoplasm Proteins
3
2019
553
0.270
Why?
Aneuploidy
2
2007
60
0.270
Why?
Cell Transformation, Neoplastic
4
2026
466
0.270
Why?
Melanoma
2
2024
523
0.260
Why?
Drug Resistance, Neoplasm
4
2023
671
0.260
Why?
Young Adult
14
2025
7598
0.260
Why?
Lymph Nodes
3
2020
563
0.250
Why?
Skin Neoplasms
2
2024
638
0.250
Why?
Neoplasm Recurrence, Local
2
2016
1538
0.240
Why?
Pyrazoles
2
2018
162
0.240
Why?
Ploidies
1
2006
39
0.240
Why?
Keratins
1
2026
63
0.240
Why?
Plasmablastic Lymphoma
1
2026
7
0.240
Why?
Logistic Models
2
2007
1276
0.230
Why?
Proto-Oncogene Proteins c-myc
3
2026
160
0.230
Why?
Phenotype
2
2023
2673
0.230
Why?
Medical Laboratory Personnel
1
2025
4
0.230
Why?
Flavonoids
1
2006
86
0.230
Why?
Lymphoma, Follicular
1
2026
74
0.230
Why?
Observer Variation
2
2007
579
0.230
Why?
Disease-Free Survival
2
2026
1196
0.230
Why?
Tumor Microenvironment
3
2025
621
0.220
Why?
Plasma Cells
2
2019
93
0.220
Why?
Karyotyping
1
2025
220
0.220
Why?
Statistics as Topic
1
2006
229
0.220
Why?
Hematologic Diseases
1
2025
77
0.220
Why?
Adenine
3
2021
101
0.220
Why?
Erythroblasts
1
2025
27
0.220
Why?
Antineoplastic Agents
4
2023
2386
0.220
Why?
Bronchiolitis Obliterans
1
2025
37
0.220
Why?
Histiocytosis, Langerhans-Cell
1
2024
24
0.210
Why?
Biopsy
2
2019
1226
0.210
Why?
Antibodies, Bispecific
1
2025
51
0.210
Why?
Oxidative Phosphorylation
1
2024
61
0.210
Why?
Sentinel Lymph Node Biopsy
1
2024
88
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2020
110
0.200
Why?
Biomarkers
3
2023
2026
0.200
Why?
Incidental Findings
1
2024
100
0.200
Why?
Cystic Fibrosis
1
2025
124
0.200
Why?
Lupus Erythematosus, Cutaneous
1
2023
5
0.200
Why?
Cell Cycle Proteins
1
2006
420
0.190
Why?
In Situ Hybridization
4
2013
306
0.190
Why?
Sarcoma
1
2025
222
0.190
Why?
Dermatitis
1
2023
34
0.190
Why?
Exanthema
1
2023
43
0.190
Why?
Oligonucleotide Array Sequence Analysis
1
2005
700
0.180
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
68
0.180
Why?
Apoptosis
2
2023
1754
0.180
Why?
Neoplasms, Second Primary
1
2024
244
0.180
Why?
Cyclin D1
2
2016
86
0.180
Why?
Predictive Value of Tests
4
2019
1792
0.180
Why?
Neoplasm, Residual
2
2021
205
0.170
Why?
Socioeconomic Factors
1
2024
675
0.160
Why?
Cell Proliferation
2
2023
1801
0.160
Why?
Cell Nucleus
3
2008
616
0.160
Why?
Autoimmune Diseases
1
2023
262
0.160
Why?
B7-H1 Antigen
2
2023
333
0.160
Why?
Lupus Erythematosus, Systemic
1
2023
244
0.160
Why?
Cell Lineage
1
2022
334
0.160
Why?
Spleen
2
2013
375
0.160
Why?
Graft vs Host Disease
1
2023
382
0.160
Why?
Retrospective Studies
6
2026
11104
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2020
22
0.160
Why?
Chromothripsis
1
2020
9
0.160
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2021
112
0.160
Why?
Mitochondria
1
2024
653
0.160
Why?
Combined Modality Therapy
4
2015
1754
0.150
Why?
Anemia, Hemolytic, Autoimmune
1
2020
12
0.150
Why?
Inflammatory Breast Neoplasms
1
2019
4
0.150
Why?
Lung Transplantation
1
2025
390
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2023
2666
0.150
Why?
Mastitis
1
2019
6
0.150
Why?
Biopsy, Needle
3
2012
225
0.150
Why?
Sezary Syndrome
1
2019
12
0.150
Why?
Genomic Instability
1
2020
92
0.150
Why?
Urinary Bladder Neoplasms
3
2009
403
0.150
Why?
Leukemia, Promyelocytic, Acute
1
2019
48
0.150
Why?
Lymphoma, T-Cell, Cutaneous
1
2019
31
0.150
Why?
Mycosis Fungoides
1
2019
30
0.150
Why?
Clinical Competence
1
2025
873
0.150
Why?
Ki-1 Antigen
1
2019
19
0.150
Why?
Breast Diseases
1
2019
101
0.140
Why?
GATA3 Transcription Factor
1
2019
53
0.140
Why?
Lymphadenopathy
1
2019
20
0.140
Why?
Thymus Neoplasms
1
2019
48
0.140
Why?
Graft Rejection
1
2025
1189
0.140
Why?
Sulfonamides
1
2021
352
0.140
Why?
Inflammation
1
2025
1134
0.140
Why?
HSP90 Heat-Shock Proteins
1
2018
45
0.140
Why?
Cell-Free Nucleic Acids
1
2019
116
0.130
Why?
Treatment Outcome
6
2024
9806
0.130
Why?
Breast
1
2019
317
0.130
Why?
Epigenesis, Genetic
1
2022
595
0.130
Why?
Muscle, Smooth
2
2009
299
0.130
Why?
Carcinoma, Transitional Cell
2
2009
158
0.120
Why?
CD5 Antigens
1
2016
13
0.120
Why?
Coombs Test
1
2016
9
0.120
Why?
Cervical Vertebrae
1
2019
253
0.120
Why?
CD4-Positive T-Lymphocytes
2
2017
507
0.120
Why?
Burkitt Lymphoma
1
2015
32
0.110
Why?
Protein-Tyrosine Kinases
1
2016
305
0.110
Why?
In Situ Hybridization, Fluorescence
2
2019
369
0.110
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2023
44
0.110
Why?
T-Lymphocyte Subsets
1
2016
291
0.100
Why?
Gene Expression Profiling
2
2014
1572
0.100
Why?
Chediak-Higashi Syndrome
1
2013
2
0.100
Why?
Leukocytosis
1
2013
15
0.100
Why?
Blood Cell Count
1
2013
67
0.100
Why?
HLA-DR Antigens
1
2013
58
0.100
Why?
Data Mining
1
2013
45
0.100
Why?
Polymerase Chain Reaction
2
2013
895
0.100
Why?
Cohort Studies
2
2013
3242
0.100
Why?
Genes, Immunoglobulin Heavy Chain
1
2013
9
0.100
Why?
Laser Capture Microdissection
1
2013
20
0.100
Why?
Survival Rate
2
2019
2057
0.090
Why?
Carcinoma
2
2024
442
0.090
Why?
Immunoenzyme Techniques
1
2013
291
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2013
889
0.090
Why?
Viral Load
1
2013
162
0.090
Why?
Cell Line, Tumor
3
2023
2913
0.090
Why?
Neoplasms, Multiple Primary
2
2010
100
0.090
Why?
DNA, Viral
1
2013
238
0.090
Why?
Gene Rearrangement
1
2013
175
0.090
Why?
Pseudolymphoma
1
2011
7
0.080
Why?
Cell Separation
1
2011
201
0.080
Why?
Mice
5
2024
12762
0.080
Why?
Mucous Membrane
2
2009
83
0.080
Why?
Urothelium
2
2009
67
0.080
Why?
Oral Ulcer
1
2010
3
0.080
Why?
Herpesvirus 4, Human
1
2011
127
0.080
Why?
Skin Diseases, Infectious
1
2010
8
0.080
Why?
Skin Ulcer
1
2010
28
0.080
Why?
fas Receptor
1
2010
73
0.080
Why?
Rituximab
2
2023
138
0.080
Why?
Piperazines
1
2012
308
0.080
Why?
Recurrence
3
2023
1274
0.080
Why?
Family Health
1
2010
157
0.080
Why?
Fatal Outcome
1
2010
295
0.070
Why?
Databases, Factual
1
2013
1102
0.070
Why?
Bone Marrow Transplantation
1
2010
287
0.070
Why?
Gastrointestinal Diseases
1
2010
156
0.070
Why?
Mutation, Missense
1
2010
312
0.070
Why?
Myoepithelioma
1
2008
15
0.070
Why?
Parotid Neoplasms
1
2008
22
0.070
Why?
Case-Control Studies
1
2013
2017
0.070
Why?
Muscle Proteins
1
2009
131
0.070
Why?
Neuroectodermal Tumors, Primitive, Peripheral
1
2007
7
0.070
Why?
Adenoma, Oxyphilic
1
2008
37
0.070
Why?
Karyotype
2
2019
34
0.070
Why?
Cytoskeletal Proteins
1
2009
225
0.070
Why?
Discriminant Analysis
1
2007
64
0.070
Why?
Sarcoma, Ewing
1
2007
42
0.070
Why?
Child
2
2025
7771
0.060
Why?
Regression Analysis
1
2008
578
0.060
Why?
Sarcoma, Synovial
1
2007
20
0.060
Why?
Infant
2
2025
3368
0.060
Why?
Immune Tolerance
1
2010
388
0.060
Why?
Antibodies
1
2009
349
0.060
Why?
Vaginal Smears
1
2007
71
0.060
Why?
Histological Techniques
1
2006
33
0.060
Why?
Uterine Cervical Dysplasia
1
2007
36
0.060
Why?
Photometry
1
2006
12
0.060
Why?
Germ-Line Mutation
1
2010
404
0.060
Why?
Cytogenetic Analysis
1
2006
70
0.060
Why?
Genomics
2
2025
914
0.060
Why?
Testicular Neoplasms
1
2007
126
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2006
35
0.060
Why?
Soft Tissue Neoplasms
1
2007
127
0.060
Why?
Papillomaviridae
1
2007
184
0.060
Why?
Signal Transduction
3
2023
3642
0.060
Why?
Caspase 3
1
2006
161
0.060
Why?
Retinoblastoma Protein
1
2006
68
0.060
Why?
Poly(ADP-ribose) Polymerases
1
2006
63
0.060
Why?
Genetic Markers
1
2006
471
0.060
Why?
Animals
5
2024
29045
0.060
Why?
Follow-Up Studies
1
2013
4049
0.060
Why?
Urinary Bladder
1
2007
263
0.060
Why?
United States
3
2025
8387
0.060
Why?
Prostate-Specific Antigen
1
2007
356
0.060
Why?
Pathologists
1
2025
44
0.050
Why?
Cytological Techniques
1
2005
30
0.050
Why?
Immunosuppressive Agents
1
2010
1021
0.050
Why?
Antigens, CD19
1
2025
90
0.050
Why?
Sentinel Lymph Node
1
2024
23
0.050
Why?
India
1
2005
148
0.050
Why?
Protein Kinase Inhibitors
2
2021
642
0.050
Why?
Eosinophils
1
2025
196
0.050
Why?
ROC Curve
1
2006
797
0.050
Why?
Allografts
1
2025
221
0.050
Why?
Vincristine
1
2023
102
0.050
Why?
Models, Statistical
1
2007
602
0.050
Why?
Repressor Proteins
1
2007
450
0.050
Why?
bcl-X Protein
1
2023
57
0.050
Why?
Papillomavirus Infections
1
2007
311
0.050
Why?
Neutrophils
1
2025
346
0.050
Why?
Prostatectomy
1
2006
491
0.050
Why?
Proto-Oncogene Proteins
1
2007
687
0.050
Why?
Prednisone
1
2023
252
0.050
Why?
Gene Deletion
1
2024
355
0.050
Why?
Cyclophosphamide
1
2023
285
0.050
Why?
Doxorubicin
1
2023
285
0.050
Why?
Receptors, Immunologic
1
2023
143
0.050
Why?
Prospective Studies
2
2023
4837
0.050
Why?
Oligopeptides
1
2023
205
0.040
Why?
Chronic Disease
1
2025
991
0.040
Why?
Social Determinants of Health
1
2024
149
0.040
Why?
Immunotherapy, Adoptive
1
2025
336
0.040
Why?
Single-Cell Analysis
1
2024
227
0.040
Why?
T-Lymphocytes, Regulatory
1
2024
358
0.040
Why?
Dendritic Cells
1
2024
547
0.040
Why?
Receptors, Antigen, B-Cell
1
2021
106
0.040
Why?
Emperipolesis
1
2019
2
0.040
Why?
Chromosomes, Human, Pair 17
1
2020
110
0.040
Why?
Myeloid Progenitor Cells
1
2019
16
0.040
Why?
Ipilimumab
1
2020
69
0.040
Why?
Erythroid Cells
1
2019
17
0.040
Why?
Disease Progression
2
2019
1621
0.040
Why?
S100 Proteins
1
2019
51
0.040
Why?
Megakaryocytes
1
2019
39
0.040
Why?
Risk Assessment
1
2007
2604
0.040
Why?
Cell Adhesion
1
2021
421
0.040
Why?
Image Processing, Computer-Assisted
1
2006
1305
0.040
Why?
Tumor Cells, Cultured
1
2021
1029
0.040
Why?
Antifungal Agents
1
2020
127
0.040
Why?
Cyclosporine
1
2020
241
0.040
Why?
Gene Dosage
1
2020
216
0.040
Why?
Tretinoin
1
2019
130
0.040
Why?
Myeloid Cells
1
2019
126
0.040
Why?
Immediate-Early Proteins
1
2020
160
0.040
Why?
Benzodioxoles
1
2018
15
0.030
Why?
Fibrosis
1
2019
235
0.030
Why?
Mortality
1
2019
160
0.030
Why?
Staining and Labeling
1
2019
161
0.030
Why?
Artificial Intelligence
1
2023
489
0.030
Why?
Purines
1
2018
97
0.030
Why?
Histiocytes
1
2017
22
0.030
Why?
Child, Preschool
1
2025
4053
0.030
Why?
World Health Organization
2
2007
125
0.030
Why?
Disease Models, Animal
1
2024
2581
0.030
Why?
Infant, Newborn
1
2023
2556
0.030
Why?
Time Factors
1
2006
5586
0.030
Why?
Surveys and Questionnaires
1
2025
3058
0.030
Why?
src Homology Domains
1
2016
46
0.030
Why?
Xenograft Model Antitumor Assays
1
2018
559
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2023
1105
0.030
Why?
NF-kappa B
1
2019
424
0.030
Why?
Neoplasm Invasiveness
2
2007
583
0.030
Why?
DNA Mutational Analysis
1
2016
554
0.030
Why?
Risk Factors
1
2025
6295
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2019
1400
0.020
Why?
Blotting, Southern
1
2013
107
0.020
Why?
Survival Analysis
1
2016
1530
0.020
Why?
High-Throughput Nucleotide Sequencing
1
2016
588
0.020
Why?
Pancytopenia
1
2012
17
0.020
Why?
Imatinib Mesylate
1
2012
129
0.020
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2011
16
0.020
Why?
Neoplasm Metastasis
1
2015
1102
0.020
Why?
Developed Countries
1
2011
25
0.020
Why?
Benzamides
1
2012
260
0.020
Why?
Gene Rearrangement, T-Lymphocyte
1
2010
18
0.020
Why?
Remission, Spontaneous
1
2010
45
0.020
Why?
Genes, Immunoglobulin
1
2010
62
0.020
Why?
Mouth Mucosa
1
2010
72
0.020
Why?
Antibody Specificity
1
2009
125
0.020
Why?
Fractures, Compression
1
2007
22
0.020
Why?
Cytoplasm
1
2008
276
0.020
Why?
Pathology
1
2007
36
0.020
Why?
Hyperplasia
1
2007
149
0.020
Why?
Societies, Scientific
1
2007
40
0.020
Why?
Bone Screws
1
2007
74
0.020
Why?
Tissue Array Analysis
1
2007
135
0.020
Why?
Spinal Fractures
1
2007
105
0.020
Why?
Aging
1
2011
772
0.010
Why?
Urology
1
2007
145
0.010
Why?
Age Factors
1
2010
1976
0.010
Why?
Lumbar Vertebrae
1
2007
376
0.010
Why?
Societies, Medical
1
2007
687
0.010
Why?
Prostate
1
2006
434
0.010
Why?
Spinal Fusion
1
2007
373
0.010
Why?
Sensitivity and Specificity
1
2007
1946
0.010
Why?
Practice Guidelines as Topic
1
2007
1116
0.010
Why?
Magnetic Resonance Imaging
1
2007
3622
0.010
Why?
Venkataraman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (375)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_